Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2019;69:7–34.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–2128.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Pereira SP, Oldfield L, Ney A, et al. Early detection of pancreatic cancer. Lancet Gastroenterol Hepatol. 2020;5:698–710.
   PubMed Web of Science ®Google Scholar
• Grat M, Stypulkowski J, Morawski M, et al. Shadows behind using simple risk models in selection of hepatocellular carcinoma patients for liver transplantation. Ann Surg. 2020;271:1124–1131.
   PubMed Web of Science ®Google Scholar
• Gurakar A, Ma M, Garonzik-Wang J, et al. Clinicopathological distinction of low-AFP-secreting vs. High-AFP-secreting hepatocellular carcinomas. Ann Hepatol. 2018;17:1052–1066.
   PubMed Web of Science ®Google Scholar
• Zekri AR, Youssef AS, Bakr YM, et al. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: a mathematical model. World J Gastroenterol. 2016;22:4168–4182.
   PubMed Web of Science ®Google Scholar
• Helaly GF, Abou Shamaa LA. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC. Egypt J Immunol. 2006;13:27–38.
   PubMedGoogle Scholar
• Sun W, Liu Y, Shou D, et al. AFP (alpha fetoprotein): who are you in gastrology? Cancer Lett. 2015;357:43–46.
   PubMed Web of Science ®Google Scholar
• Zhu PP, Yuan SG, Liao Y, et al. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. World J Gastroenterol. 2015;21:7254–7263.
   PubMed Web of Science ®Google Scholar
• Gillespie JR, Uversky VN. Structure and function of alpha-fetoprotein: a biophysical overview. Biochim Biophys Acta. 2000;1480:41–56.
   PubMed Web of Science ®Google Scholar
• Bui TM, Wiesolek HL, Sumagin R. ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. 2020;108:787–799.
   PubMed Web of Science ®Google Scholar
• Zhu W, Peng Y, Wang L, et al. Identification of alpha-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy. Hepatology. 2018;68:574–589.
   PubMed Web of Science ®Google Scholar
• Jackson AM, Alexandrov AB, Gribben SC, et al. Expression and shedding of ICAM-1 in bladder cancer and its immunotherapy. Int J Cancer. 1993;55:921–925.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang X, Chen X, et al. Novel immune-related gene signature for risk stratification and prognosis of survival in lower-grade glioma. Front Genet. 2020;11:363.
   PubMed Web of Science ®Google Scholar
• Kang JS, Lee C, Song W, et al. Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning. Sci Rep. 2020;10:20140.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li H, Zhang W, et al. LASSObased CoxPH model identifies an 11lncRNA signature for prognosis prediction in gastric cancer. Mol Med Rep. 2018;18:5579–5593.
   PubMed Web of Science ®Google Scholar
• Dong X, Gu DN, Wang O, et al. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment. Int Immunopharmacol. 2020;87:106793.
   PubMed Web of Science ®Google Scholar
• Zhang X, Shi M, Chen T, et al. Characterization of the immune cell infiltration landscape in head and neck squamous cell carcinoma to aid immunotherapy. Mol Ther Nucleic Acids. 2020;22:298–309.
   PubMedGoogle Scholar
• Wang J, Sun J, Liu LN, et al. Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy. Nat Med. 2019;25:656–666.
   PubMed Web of Science ®Google Scholar
• Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550–1558.
   PubMed Web of Science ®Google Scholar
• Xu S, Tang L, Dai G, et al. Expression of m6A regulators correlated with immune microenvironment predicts therapeutic efficacy and prognosis in gliomas. Front Cell Dev Biol. 2020;8:594112.
   PubMed Web of Science ®Google Scholar
• Sasikumar PG, Ramachandra M. Small-molecule immune checkpoint inhibitors targeting PD-1/PD-L1 and other emerging checkpoint pathways. BioDrugs. 2018;32:481–497.
   PubMed Web of Science ®Google Scholar
• Curran MA, Montalvo W, Yagita H, et al. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci U S A. 2010;107:4275–4280.
   PubMed Web of Science ®Google Scholar
• Northen A, Asendorf T, Walson PD, et al. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation. Clin Biochem. 2018;52:20–25.
   PubMed Web of Science ®Google Scholar
• Witkowska AM, Borawska MH. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw. 2004;15:91–98.
   PubMed Web of Science ®Google Scholar
• Shimura T, Shibata M, Gonda K, et al. Prognostic impact of soluble intercellular adhesion molecule-1 in hepatocellular carcinoma. Oncol Lett. 2018;16:6013–6018.
   PubMed Web of Science ®Google Scholar
• Wang R, Li J, Xu D, et al. Dynamic change in serum alpha-fetoprotein level predicts treatment response and prognosis of alpha-fetoprotein-producing gastric cancer. Medicine (Baltimore). 2020;99:e23326.
   PubMed Web of Science ®Google Scholar
• Loglio A, Iavarone M, Facchetti F, et al. The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy. Liver Int. 2020;40:1987–1996.
   PubMed Web of Science ®Google Scholar
• Dai M, Chen X, Liu X, et al. Diagnostic value of the combination of golgi protein 73 and alpha-fetoprotein in hepatocellular carcinoma: a meta-analysis. PLoS One. 2015;10:e0140067.
   PubMed Web of Science ®Google Scholar
• Toyoda H, Kumada T, Tada T, et al. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL. Cancer Sci. 2011;102:1025–1031.
   PubMed Web of Science ®Google Scholar
• Jia D, Li S, Li D, et al. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Aging (Albany NY). 2018;10:592–605.
   PubMedGoogle Scholar
• Zhang FP, Huang YP, Luo WX, et al. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. World J Gastroenterol. 2020;26:134–153.
   PubMed Web of Science ®Google Scholar
• Ganjalikhani Hakemi M, Jafarinia M, Azizi M, et al. The role of TIM-3 in hepatocellular carcinoma: a promising target for immunotherapy? Front Oncol. 2020;10:601661.
   PubMed Web of Science ®Google Scholar
• Zahran AM, Hetta HF, Rayan A, et al. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes. Cancer Immunol Immunother. 2020;69:1253–1263.
   PubMed Web of Science ®Google Scholar